Page last updated: 2024-11-03

rabeprazole and Anemia

rabeprazole has been researched along with Anemia in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khalife, W1
Murunga, E1
Mahmoud, F1

Other Studies

1 other study available for rabeprazole and Anemia

ArticleYear
Idiopathic pure red cell aplasia: case report with review of literature.
    South Dakota journal of medicine, 2005, Volume: 58, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anemia; Benzimidazoles; Enzyme Inhibitors; Humans; Ma

2005